Corvus Pharmaceuticals Inc (C17) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	8.45M	9.94M	11.18M	15.96M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.12M	2.28M	3.70M	3.33M
Operating expense	10.57M	12.22M	14.88M	19.30M
Total operating expenses	10.57M	12.22M	14.88M	19.30M
Operating income	-10.57M	-12.22M	-14.88M	-19.30M
Other non operating income	-	-	-	-
EBT including unusual items	-10.16M	-12.32M	-13.69M	-17.96M
EBT excluding unusual items	-10.16M	-12.32M	-13.69M	-17.96M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-10.16M	-12.32M	-13.69M	-17.96M
Net profit margin	-	-	-	-
Earnings per share	-0.12	-0.15	-0.15	-0.19
Interest and investment income	738.00K	603.00K	1.78M	2.05M
Interest expense	-	-	-	-
Net interest expenses	738.00K	603.00K	1.78M	2.05M
Depreciation and amortization charges	-	-	-	-
EBITDA	-10.54M	-12.19M	-14.85M	-19.26M
Gain or loss from assets sale	-	-	-	-

Ask anything